Ptc Therapeutics (PTCT) Exchange Rate Effect (2015 - 2026)
Ptc Therapeutics (PTCT) posted quarterly Exchange Rate Effect of -$2.5 million for Q2 2026, down 118.68% year-over-year from $13.6 million in Q2 2025, and down 66.54% quarter-over-quarter from -$1.5 million in Q1 2026.
Ptc Therapeutics (PTCT) Exchange Rate Effect (2015 - 2026) Analysis & Trends
Ptc Therapeutics' Exchange Rate Effect history runs 12 years deep, the most recent figure standing at -$2.5 million for Q2 2026.
- In Q2 2026, Exchange Rate Effect fell 118.68% year-over-year to -$2.5 million; the TTM figure through Jun 2026 stood at -$331000.0 (down 101.75% YoY), while the FY2025 annual figure was $22.7 million, up 409.93% from the prior year.
- Exchange Rate Effect for Q2 2026 stood at -$2.5 million, down from -$1.5 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $13.6 million in Q2 2025, with the low at -$12.1 million in Q3 2022.
- The 5-year median for Exchange Rate Effect is $64500.0 (2022), against an average of $648000.0.
- Peak annual rise in Exchange Rate Effect reached 508.85% in 2023, while the deepest fall reached 581.73% in 2023.
- Ptc Therapeutics' Exchange Rate Effect stood at $6.0 million in 2022, then tumbled by 48.59% to $3.1 million in 2023, then plunged by 379.58% to -$8.7 million in 2024, then soared by 213.2% to $9.8 million in 2025, then plunged by 125.91% to -$2.5 million in 2026.
- Business Quant data shows PTCT's Exchange Rate Effect at -$2.5 million in Q2 2026, -$1.5 million in Q1 2026, and $9.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Ptc Therapeutics | 5.97 Bn | 3.75 Bn | 340.60 Mn | -2.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.54 Mn |
| Jun 30, 2026 | -2.54 Mn |
| Mar 31, 2026 | -1.52 Mn |
| Mar 31, 2026 | -1.52 Mn |
| Dec 31, 2025 | 9.80 Mn |
| Dec 31, 2025 | 9.80 Mn |
| Sep 30, 2025 | -6.06 Mn |
| Sep 30, 2025 | -6.06 Mn |
| Jun 30, 2025 | 13.59 Mn |
| Jun 30, 2025 | 13.59 Mn |
| Mar 31, 2025 | 5.39 Mn |
| Mar 31, 2025 | 5.39 Mn |
| Dec 31, 2024 | -8.65 Mn |
| Dec 31, 2024 | -8.65 Mn |
| Sep 30, 2024 | 8.54 Mn |
| Sep 30, 2024 | 8.54 Mn |
| Jun 30, 2024 | -5.19 Mn |
| Jun 30, 2024 | -5.19 Mn |
| Mar 31, 2024 | -2.03 Mn |
| Mar 31, 2024 | -2.03 Mn |